| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |